Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hillel Halkin

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Clinical Pharmacology and Therapeutics|November 17, 2021
Pharmacokinetic Drug Interactions of the New Oral Anticoagulants RevisitedHillel Halkin
Clinical Pharmacology and Therapeutics|February 22, 2020
A Commentary on "Ischemic Stroke and Systemic Embolism in Warfarin Users With Atrial Fibrillation or Heart Valve Replacement Exposed to Dicloxacillin or Flucloxacillin"Hillel Halkin
The Israel Medical Association Journal : IMAJ|August 8, 2006
The evidence behind our evidence-based decisions: cheques and balancesHillel Halkin
Harefuah|August 12, 2003
[Computerized physician order entry--an urgently required modality]Hillel Halkin
Pharmacogenomics|October 16, 2008
Shifting paradigms in the pharmacogenetics of warfarinEva Gak, Hillel Halkin
Harefuah|November 3, 2006
[Generic drug substitution]Orly Tamir, Hillel Halkin, Joshua Shemer
Gut|November 30, 2017
Proton pump inhibitors and the risk for gastric cancer: possible confounding by serum vitamin B <sub></sub>Itai Gueta, Hillel Halkin, Noa Markovits, et al.
British Journal of Clinical Pharmacology|October 17, 2020
Concomitant oral potassium chloride and anticholinergic therapy is associated with upper gastrointestinal bleeding: A cohort studyItai Gueta, Noa Markovits, Hillel Halkin, et al.
British Journal of Clinical Pharmacology|July 27, 2010
Warfarin and vitamin K intake in the era of pharmacogeneticsYael Lurie, Ronen Loebstein, Daniel Kurnik, et al.
Pharmacogenomics|December 5, 2009
10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisalDaniel Kurnik, Ronen Loebstein, Hillel Halkin, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|November 17, 2021
Pharmacokinetic Drug Interactions of the New Oral Anticoagulants RevisitedHillel Halkin
Clinical Pharmacology and Therapeutics|February 22, 2020
A Commentary on "Ischemic Stroke and Systemic Embolism in Warfarin Users With Atrial Fibrillation or Heart Valve Replacement Exposed to Dicloxacillin or Flucloxacillin"Hillel Halkin
The Israel Medical Association Journal : IMAJ|August 8, 2006
The evidence behind our evidence-based decisions: cheques and balancesHillel Halkin
Harefuah|August 12, 2003
[Computerized physician order entry--an urgently required modality]Hillel Halkin
Pharmacogenomics|October 16, 2008
Shifting paradigms in the pharmacogenetics of warfarinEva Gak, Hillel Halkin
Harefuah|November 3, 2006
[Generic drug substitution]Orly Tamir, Hillel Halkin, Joshua Shemer
Gut|November 30, 2017
Proton pump inhibitors and the risk for gastric cancer: possible confounding by serum vitamin B <sub></sub>Itai Gueta, Hillel Halkin, Noa Markovits, et al.
British Journal of Clinical Pharmacology|October 17, 2020
Concomitant oral potassium chloride and anticholinergic therapy is associated with upper gastrointestinal bleeding: A cohort studyItai Gueta, Noa Markovits, Hillel Halkin, et al.
British Journal of Clinical Pharmacology|July 27, 2010
Warfarin and vitamin K intake in the era of pharmacogeneticsYael Lurie, Ronen Loebstein, Daniel Kurnik, et al.
Pharmacogenomics|December 5, 2009
10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisalDaniel Kurnik, Ronen Loebstein, Hillel Halkin, et al.
Pageof 5